Susan M. Love, MD, MBA has dedicated her professional life to the eradication of breast cancer. As Founder and Chief Visionary Officer of Dr. Susan Love Research Foundation, she oversees an active research program centered on breast cancer cause and prevention. She was also a Clinical Professor of Surgery at UCLA’s David Geffen School of Medicine.
Dr. Love received her medical degree from SUNY Downstate Medical Center in New York and did her surgical training at Boston’s Beth Israel Hospital. She founded the Faulkner Breast Center in Boston and the Revlon UCLA Breast Center in Los Angeles. She has a business degree from the Executive MBA program at UCLA’s Anderson School. In 1996, she retired from the active practice of surgery, to dedicate her time to the urgent pursuit of finding the cause and prevention of breast cancer. She has done this in the private and nonprofit arenas including creating several medical device companies based on the intraductal approach to the breast.
Her reputation as an activist comes from her role as one of the “founding mothers” of the breast cancer advocacy movement in the early 1990’s as one of the founders of the National Breast Cancer Coalition (NBCC). She continues this work by serving on the boards of the National Breast Cancer Coalition and Young Survival Coalition. She served on the National Cancer Advisory Board from 1998-2004 as an appointment of President Clinton.
Dr. Susan Love is best-known as a trusted guide to women worldwide through her books, the Foundation website and social media. The completely revised fifth edition of Dr. Susan Love’s Breast Book termed “the bible for women with breast cancer” by The New York Times was released October 2010. It has been translated into German, Dutch, Chinese, Japanese, Spanish, and Hebrew. Dr. Susan Love’s Menopause and Hormone Book, first published in 1998 and revised in 2003, was one of the first to sound the alarm against the long term use of postmenopausal hormones. Live a Little (Crown 2009) encourages women to take a reasonable approach to becoming healthy.
A true visionary, Susan Love’s recent projects include the Love Research Army, a creative Internet solution to partner women and scientists to accelerate basic translational research. Since its inception in 2008, the Love Research Army has attracted more than 376,000 volunteers who are willing to consider participating in research to find the cause and prevention of breast cancer. This novel initiative is moving more research from animals to women, democratizing the scientific process. In October 2012, the Foundation launched the Health of Women [HOW] Study™, a long-term online cohort study to identify the cause of breast cancer.
In June of 2012, Susan Love was diagnosed with leukemia and underwent chemotherapy and a stem cell transplant. She returned to work in January of 2013 more determined than ever to find the cause of cancer and end it once and for all.
In 2019, Dr. Susan Love received the Harriet Benjamin Inspiration Award at the Spirit of Community luncheon held by the Cancer Support Community Los Angeles at the Skirball Cultural Center. Dr. Love was honored for her lifetime of work dedicated to the eradication of breast cancer.
On February 7 & 8, 2020, Dr. Susan Love hosted the 10th International Symposium on the Human Breast at the UCLA Meyer & Renee Luskin Conference Center. The Symposium gathers world-class researchers, clinicians, and advocates from multiple disciplines in an intimate think-tank environment to stimulate ideas, collaboration, seed-funding opportunities, and ultimately breakthroughs that will end breast cancer.
Dr. Love’s fierce intellect, unrelenting tenacity, and laser-like focus, has led to some of the world’s more innovative research. From spearheading a partnership with NASA’s Jet Propulsion Laboratory to mapping the breast ductal system, to harnessing the power of artificial intelligence to develop a handheld, self-reading ultrasound for breast cancer screening in underserved populations, Dr. Love’s goal remains simple and clear: to end breast cancer.